Submit Manuscript Other Thematic Issue Proposal Browse Thematic Issue Become a Reviewer

Share this:

Visibility on Science Direct (Elsevier) also if published as Open Access.

Member Institutions enjoy complementary or discounted APCs.

Quick and simple submission process.

Journal Information

AI in Precision Oncology and Psycho-Oncology

Journal: Clinical Cancer Drugs
Guest editor(s): Dr. Kadir Uludag Xuan Wu Hospital Of The Capital Medical University, Beijing, China | Xuan Wu Hospital Of The Capital Medical University, Beijing, China
Co-Guest Editor(s): Dr. Yanhua Bi Zhejiang University Children's Hospital, Hangzhou, China
Submission closes on: 02^nd October, 2026

Submit Manuscript

Introduction

The scope of this project encompasses several cutting-edge areas at the intersection of artificial intelligence and oncology. First, it involves developing AI models for drug response prediction and biomarker discovery, enabling more accurate and personalized treatment strategies. Second, it focuses on predictive models for mental health outcomes in cancer patients, addressing critical psychological challenges. Third, AI-based interventions will be explored for managing anxiety, depression, and stress, common but often overlooked in oncology. Finally, the project aims to build integrative platforms for clinical decision support. Together, these efforts bridge personalized medicine with mental well-being, a crucial priority in cancer care.

Keywords

AI, oncology, psychooncology, precision psychiatry, personalized treatment, anxiety, depression

Sub-topics

AI-Based Interventions for Anxiety, Depression, and Stress
Anxiety and Oncology
Depression and Oncology